ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      57,816.40
      2.06%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      05/04/20174:05PMGlobeNewswire Inc.Esperion Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2017 Financial ResultsNASDAQ:ESPREsperion Therapeutics Inc
      04/20/20174:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20174:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20176:51AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20176:51AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20176:51AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20176:50AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20176:50AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      04/19/20176:50AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      03/28/20174:30PMGlobeNewswire Inc.Esperion to Participate in Fireside Chat at the 16th Annual Needham Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      03/27/20175:23PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ESPREsperion Therapeutics Inc
      03/23/20174:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      03/23/20174:41PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
      03/23/20174:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      03/22/20178:03AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      03/20/20177:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      03/20/20177:30AMGlobeNewswire Inc.Esperion Announces FDA Confirmation Regarding Regulatory Pathway to Approval for an LDL-C Lowering Indication for Bempedoic A...NASDAQ:ESPREsperion Therapeutics Inc
      03/07/20178:47AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      03/07/20178:30AMGlobeNewswire Inc.Esperion Announces Initiation of Phase 2 Triplet Oral Therapy Study of Bempedoic Acid/Ezetimibe/AtorvastatinNASDAQ:ESPREsperion Therapeutics Inc
      03/06/20178:30AMGlobeNewswire Inc.Esperion Announces Oral Presentation on Genetic Validation of ATP Citrate Lyase Inhibition at the American College of Cardiol...NASDAQ:ESPREsperion Therapeutics Inc
      03/06/20178:05AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ESPREsperion Therapeutics Inc
      03/06/20178:02AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ESPREsperion Therapeutics Inc
      02/22/20176:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      02/22/20176:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      02/22/20176:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      02/22/20174:39PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ESPREsperion Therapeutics Inc
      02/22/20174:35PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ESPREsperion Therapeutics Inc
      02/22/20177:47AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      02/22/20177:30AMGlobeNewswire Inc.Esperion Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2016 Financial ResultsNASDAQ:ESPREsperion Therapeutics Inc
      02/15/20174:30PMGlobeNewswire Inc.Esperion to Participate in Fireside Chat at RBC Capital Markets Global Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR